Gossamer Bio (GOSS) EBIAT (2022 - 2025)
Historic EBIAT for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$48.2 million.
- Gossamer Bio's EBIAT fell 5654.64% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.2 million, marking a year-over-year decrease of 11795.89%. This contributed to the annual value of -$56.5 million for FY2024, which is 6856.36% up from last year.
- As of Q3 2025, Gossamer Bio's EBIAT stood at -$48.2 million, which was down 5654.64% from -$38.3 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's EBIAT registered a high of $49.2 million during Q2 2024, and its lowest value of -$59.4 million during Q3 2022.
- Moreover, its 4-year median value for EBIAT was -$42.5 million (2023), whereas its average is -$39.3 million.
- As far as peak fluctuations go, Gossamer Bio's EBIAT skyrocketed by 21585.09% in 2024, and later crashed by 17774.01% in 2025.
- Gossamer Bio's EBIAT (Quarter) stood at -$55.8 million in 2022, then rose by 13.66% to -$48.1 million in 2023, then surged by 31.4% to -$33.0 million in 2024, then tumbled by 46.0% to -$48.2 million in 2025.
- Its EBIAT stands at -$48.2 million for Q3 2025, versus -$38.3 million for Q2 2025 and -$36.6 million for Q1 2025.